SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-21-008336
Filing Date
2021-07-29
Accepted
2021-07-29 17:15:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS vtgndef14a_july2021.htm DEFA14A 19913
2 IMAGE notice000.jpg GRAPHIC 110982
3 IMAGE notice001.jpg GRAPHIC 95848
  Complete submission text file 0001654954-21-008336.txt   306055
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37761 | Film No.: 211128565
SIC: 2834 Pharmaceutical Preparations